| Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018 L Galluzzi, I Vitale, SA Aaronson, JM Abrams, D Adam, P Agostinis, ... Cell Death & Differentiation 25 (3), 486-541, 2018 | 6328 | 2018 |
| Two distinct estrogen‐regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B. P Kastner, A Krust, B Turcotte, U Stropp, L Tora, H Gronemeyer, ... The EMBO journal 9 (5), 1603-1614, 1990 | 1985 | 1990 |
| Principles for modulation of the nuclear receptor superfamily H Gronemeyer, JÅ Gustafsson, V Laudet Nature reviews Drug discovery 3 (11), 950-964, 2004 | 1562 | 2004 |
| Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-α W Bourguet, M Ruff, P Chambon, H Gronemeyer, D Moras Nature 375 (6530), 377-382, 1995 | 1520 | 1995 |
| Crystal structure of the RAR-γ ligand-binding domain bound to all-trans retinoic acid JP Renaud, N Rochel, M Ruff, V Vivat, P Chambon, H Gronemeyer, ... Nature 378 (6558), 681-689, 1995 | 1421 | 1995 |
| TIF2, a 160 kDa transcriptional mediator for the ligand‐dependent activation function AF‐2 of nuclear receptors. JJ Voegel, MJ Heine, C Zechel, P Chambon, H Gronemeyer The EMBO journal 15 (14), 3667-3675, 1996 | 1325 | 1996 |
| A canonical structure for the ligand-binding domain of nuclear receptors JM Wurtz, W Bourguet, JP Renaud, V Vivat, P Chambon, D Moras, ... Nature structural biology 3 (1), 87-94, 1996 | 1233 | 1996 |
| Essential versus accessory aspects of cell death: recommendations of the NCCD 2015 L Galluzzi, BS Pedro, I Vitale, SA Aaronson, JM Abrams, D Adam, ... Cell Death & Differentiation 22 (1), 58-73, 2015 | 1224 | 2015 |
| A unified nomenclature system for the nuclear receptor superfamily J Auwerx, E Baulieu, M Beato, M Becker-Andre, PH Burbach, G Camerino, ... Cell 97 (2), 161-163, 1999 | 1201 | 1999 |
| The nuclear receptor ligand-binding domain: structure and function D Moras, H Gronemeyer Current opinion in cell biology 10 (3), 384-391, 1998 | 1135 | 1998 |
| Senescence-associated reprogramming promotes cancer stemness M Milanovic, DNY Fan, D Belenki, JHM Däbritz, Z Zhao, Y Yu, JR Dörr, ... Nature 553 (7686), 96-100, 2018 | 1019 | 2018 |
| The promise of retinoids to fight against cancer L Altucci, H Gronemeyer Nature Reviews Cancer 1 (3), 181-193, 2001 | 986 | 2001 |
| Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes L Galluzzi, SA Aaronson, J Abrams, ES Alnemri, DW Andrews, ... Cell Death & Differentiation 16 (8), 1093-1107, 2009 | 869 | 2009 |
| The N‐terminal part of TIF1, a putative mediator of the ligand‐dependent activation function (AF‐2) of nuclear receptors, is fused to B‐raf in the oncogenic protein T18. B Le Douarin, C Zechel, JM Garnier, Y Lutz, L Tora, P Pierrat, D Heery, ... The EMBO journal 14 (9), 2020-2033, 1995 | 736 | 1995 |
| Steroid hormone receptors compete for factors that mediate their enhancer function ME Meyer, H Gronemeyer, B Turcotte, MT Bocquel, D Tasset, P Chambon Cell 57 (3), 433-442, 1989 | 697 | 1989 |
| Nuclear receptor ligand-binding domains: three-dimensional structures, molecular interactions and pharmacological implications W Bourguet, P Germain, H Gronemeyer Trends in pharmacological sciences 21 (10), 381-388, 2000 | 659 | 2000 |
| RAR and RXR modulation in cancer and metabolic disease L Altucci, MD Leibowitz, KM Ogilvie, AR de Lera, H Gronemeyer Nature reviews Drug discovery 6 (10), 793-810, 2007 | 642 | 2007 |
| Tumor-selective action of HDAC inhibitors involves TRAIL induction in acute myeloid leukemia cells A Nebbioso, N Clarke, E Voltz, E Germain, C Ambrosino, P Bontempo, ... Nature medicine 11 (1), 77-84, 2005 | 618 | 2005 |
| The coactivator TIF2 contains three nuclear receptor‐binding motifs and mediates transactivation through CBP binding‐dependent and‐independent pathways JJ Voegel, MJS Heine, M Tini, V Vivat, P Chambon, H Gronemeyer The EMBO journal, 1998 | 615 | 1998 |
| International union of pharmacology. LXIII. Retinoid X receptors P Germain, P Chambon, G Eichele, RM Evans, MA Lazar, M Leid, ... Pharmacological reviews 58 (4), 760-772, 2006 | 584 | 2006 |
Lucia Altucci, MD, PhDSeconda Università di Napoli確認したメール アドレス: unina2.it
